Clinical Trials in Baltimore

Showing 16961-16980 of 23,476 trials

Biomarkers In Retinitis Pigmentosa (BIRP)

NCT01949623

In this study, markers of oxidative stress will be measured in the aqueous humour and plasma of RP patients compared to controls.

Retinitis Pigmentosa

Johns Hopkins University100 participantsStarted Sep 2013

Baltimore, Maryland, United States

COMPLETEDPhase 2< 1 mile

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00540722

This phase II trial is studying how well gossypol works in treating patients with progressive or recurrent glioblastoma multiforme. Gossypol may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more

National Cancer Institute (NCI)56 participantsStarted Jan 2008

Birmingham, Alabama, United States • Tampa, Florida, United States • Baltimore, Maryland, United States +5 more locations

COMPLETEDPhase 3< 1 mile

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial

NCT01000727

This study will test whether darapladib can safely lower the chances of having a cardiovascular event (such as a heart attack or urgent coronary revascularization (e.g. medical procedures performed to restore the normal blood flow in patients with atherosclerosis)) when treatment is started within 30 days after an acute coronary syndrome (also called ACS).

Acute Coronary Syndrome

GlaxoSmithKline13,026 participantsStarted Dec 2009

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +911 more locations

Biomarkers In Retinitis Pigmentosa (BIRP)

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial

Find Trials by Condition in Baltimore

A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis

A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies

Schizophrenia Study In Adults

A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia

Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

Interleukin-2 Treatment for Wiskott-Aldrich Syndrome

Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

Safety and Adherence of a Non-medicated Intravaginal Ring (IVR)

Safety Study to Evaluate FluMist in Immunocompromised Children

Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease

A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma

A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain

A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors